Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
CCM vs RDNT
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
CCM vs RDNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Diagnostics & Research |
| Market Cap | $748K | $4.45B |
| Revenue (TTM) | $366M | $2.04B |
| Net Income (TTM) | $-163M | $47M |
| Gross Margin | -11.4% | 11.2% |
| Operating Margin | -131.0% | 3.0% |
| Forward P/E | 1.2x | 91.8x |
| Total Debt | $3.93B | $1.86B |
| Cash & Equiv. | $216M | $767M |
CCM vs RDNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Concord Medical Ser… (CCM) | 100 | 37.0 | -63.0% |
| RadNet, Inc. (RDNT) | 100 | 337.4 | +237.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCM vs RDNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CCM is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.53
- Lower volatility, beta 0.53, current ratio 0.46x
- Beta 0.53, current ratio 0.46x
RDNT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 11.5%, EPS growth -7.7%, 3Y rev CAGR 12.6%
- 9.5% 10Y total return vs CCM's -88.8%
- 11.5% revenue growth vs CCM's -28.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.5% revenue growth vs CCM's -28.6% | |
| Value | Lower P/E (1.2x vs 91.8x) | |
| Quality / Margins | 2.3% margin vs CCM's -44.6% | |
| Stability / Safety | Beta 0.53 vs RDNT's 1.43 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +4.6% vs CCM's -28.4% | |
| Efficiency (ROA) | 1.3% ROA vs CCM's -2.4%, ROIC 2.0% vs -7.7% |
CCM vs RDNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CCM vs RDNT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
RDNT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RDNT is the larger business by revenue, generating $2.0B annually — 5.6x CCM's $366M. RDNT is the more profitable business, keeping 2.3% of every revenue dollar as net income compared to CCM's -44.6%. On growth, RDNT holds the edge at +14.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $366M | $2.0B |
| EBITDAEarnings before interest/tax | -$359M | $214M |
| Net IncomeAfter-tax profit | -$163M | $47M |
| Free Cash FlowCash after capex | $0 | -$178M |
| Gross MarginGross profit ÷ Revenue | -11.4% | +11.2% |
| Operating MarginEBIT ÷ Revenue | -131.0% | +3.0% |
| Net MarginNet income ÷ Revenue | -44.6% | +2.3% |
| FCF MarginFCF ÷ Revenue | -2.1% | -8.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.3% | +14.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +84.0% | -114.1% |
Valuation Metrics
CCM leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $748,461 | $4.5B |
| Enterprise ValueMkt cap + debt − cash | $547M | $5.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.02x | -230.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 1.23x | 91.75x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 25.88x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 2.18x |
| Price / BookPrice ÷ Book value/share | 0.00x | 3.19x |
| Price / FCFMarket cap ÷ FCF | — | 52.01x |
Profitability & Efficiency
RDNT leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
RDNT delivers a 3.8% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-10 for CCM. RDNT carries lower financial leverage with a 1.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), RDNT scores 5/9 vs CCM's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -9.8% | +3.8% |
| ROA (TTM)Return on assets | -2.4% | +1.3% |
| ROICReturn on invested capital | -7.7% | +2.0% |
| ROCEReturn on capital employed | -12.2% | +2.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 |
| Debt / EquityFinancial leverage | 2.43x | 1.37x |
| Net DebtTotal debt minus cash | $3.7B | $1.1B |
| Cash & Equiv.Liquid assets | $216M | $767M |
| Total DebtShort + long-term debt | $3.9B | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | -2.40x | 1.46x |
Total Returns (Dividends Reinvested)
RDNT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RDNT five years ago would be worth $24,710 today (with dividends reinvested), compared to $1,512 for CCM. Over the past 12 months, RDNT leads with a +4.6% total return vs CCM's -28.4%. The 3-year compound annual growth rate (CAGR) favors RDNT at 26.0% vs CCM's -27.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +20.4% | -19.0% |
| 1-Year ReturnPast 12 months | -28.4% | +4.6% |
| 3-Year ReturnCumulative with dividends | -61.4% | +100.0% |
| 5-Year ReturnCumulative with dividends | -84.9% | +147.1% |
| 10-Year ReturnCumulative with dividends | -88.8% | +947.4% |
| CAGR (3Y)Annualised 3-year return | -27.2% | +26.0% |
Risk & Volatility
Evenly matched — CCM and RDNT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CCM is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than RDNT's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RDNT currently trades 67.0% from its 52-week high vs CCM's 47.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.53x | 1.43x |
| 52-Week HighHighest price in past year | $10.77 | $85.84 |
| 52-Week LowLowest price in past year | $3.18 | $50.76 |
| % of 52W HighCurrent price vs 52-week peak | +47.7% | +67.0% |
| RSI (14)Momentum oscillator 0–100 | 67.5 | 51.3 |
| Avg Volume (50D)Average daily shares traded | 11K | 822K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CCM as "Buy" and RDNT as "Buy".
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $92.00 |
| # AnalystsCovering analysts | 2 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
RDNT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 1 tied.
CCM vs RDNT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CCM or RDNT a better buy right now?
For growth investors, RadNet, Inc.
(RDNT) is the stronger pick with 11. 5% revenue growth year-over-year, versus -28. 6% for Concord Medical Services Holdings Limited (CCM). Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CCM or RDNT?
Over the past 5 years, RadNet, Inc.
(RDNT) delivered a total return of +147. 1%, compared to -84. 9% for Concord Medical Services Holdings Limited (CCM). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus CCM's -88. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CCM or RDNT?
By beta (market sensitivity over 5 years), Concord Medical Services Holdings Limited (CCM) is the lower-risk stock at 0.
53β versus RadNet, Inc. 's 1. 43β — meaning RDNT is approximately 169% more volatile than CCM relative to the S&P 500. On balance sheet safety, RadNet, Inc. (RDNT) carries a lower debt/equity ratio of 137% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.
04Which is growing faster — CCM or RDNT?
By revenue growth (latest reported year), RadNet, Inc.
(RDNT) is pulling ahead at 11. 5% versus -28. 6% for Concord Medical Services Holdings Limited (CCM). On earnings-per-share growth, the picture is similar: Concord Medical Services Holdings Limited grew EPS -3. 6% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CCM or RDNT?
RadNet, Inc.
(RDNT) is the more profitable company, earning 2. 3% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 2. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RDNT leads at 3. 0% versus -138. 6% for CCM. At the gross margin level — before operating expenses — RDNT leads at 11. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CCM or RDNT more undervalued right now?
On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1.
2x forward P/E versus 91. 8x for RadNet, Inc. — 90. 5x cheaper on a one-year earnings basis.
07Which pays a better dividend — CCM or RDNT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is CCM or RDNT better for a retirement portfolio?
For long-horizon retirement investors, Concord Medical Services Holdings Limited (CCM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53)). Both have compounded well over 10 years (CCM: -88. 8%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CCM and RDNT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.